Rankings
▼
Calendar
VSTM Q4 2020 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$388M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$506,000
-86.0% YoY
Gross Profit
$494,000
97.6% margin
Operating Income
-$17M
-3311.1% margin
Net Income
-$20M
-3925.7% margin
EPS (Diluted)
$-1.40
QoQ Revenue Growth
-99.4%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$154M
Total Liabilities
$39M
Stockholders' Equity
$115M
Cash & Equivalents
$68M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$506,000
$4M
-86.0%
Gross Profit
$494,000
$3M
-82.9%
Operating Income
-$17M
-$33M
+49.7%
Net Income
-$20M
-$39M
+48.8%
Revenue Segments
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees
$270,000
43%
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$189,000
30%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$138,000
22%
Product Revenue And Allowances Returns
$25,000
4%
← FY 2020
All Quarters
Q1 2021 →